1The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Follow-up report on the diagnosis of diabetes mellitus[J]. Diabetes Care,2004,27(2) :$5-S10.
2Rhee SY,Chon S, Oh S,et al. Insulin secretion and insulin resistance in newly diagnosed, drug naive prediabetes and type 2 diabetes patients with/without metabolic syndrome[J]. Diabetes Res Clin Pract,2007,76(3) 397-403.
3Nathan DM. Clinical practice Initial management of glycemia in type 2 diabetes mellitus[J]. New Engl J Med,2002,347(17) : 1342-1349.
4Butler AE,Janson J, Bonnet-Weir S, et al. Beta-cell deficit and in-creased beta-cell apoptosis in humans with type 2 diabetes[J]. Diabe- tes,2003,52(1) :102-110.
6Wang JJ ,Yuan SY,Zhu LX,et al. Effects of impaired fasting glucose and impaired glucose tolerance on predicting incident type 2 diabetes in a Chinese population with high post-prandial glucose[J]. Diab Res Clin Pract,2004,66(2) :183-191.
7Chiasn JL, Josse RG, Gomis R, et al. STOP-NIDDM Trial Research Group. Acarbose treatment and the risk oI cardiovascular disease and hypertension in patients with impaired glucose tolerance: The STOP-NIDDM trial[J]. JAMA,2003,290(4) :486-494.
8The DREAM(Diabetes Reduction Assessment with ramipri[ and ros- iglitazone Medication)Trial Investigators. Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose:A randomized controlled trial[J]. Lancet, 20O6,368(51) : 1096-1105.
9Omori K,Todorov I, Shintaku J, et al. P38alpha-selective mitogen- activated protein kinase inhibitor for improvement of cultured human islet recovery[J]. Pancreas,2010,39(4):436-443.
10Ito T, Omori K,Rawson J,et al. Improvement of canine islet yield by donor pancreas infusion with a p38MAPK inhibitor[J]. Transplanta- tion, 2008,86 (2) : 321-329.
2Chung WK, Power-Kehoe L, Chua M, et al. Exonic and intronicsequence variation, in the human leptin receptor gene (LEPR)[J].Diabetes, 1997, 46(9): 1509-1511.
3Park KS, Shin HD, Park BL, et al. Polymorphisms in the leptinreceptor (LEPR)--putative association with obesity andT2DM[J].JHum Genet, 2006, 51(2): 85-91.
4Kieffer TJ, Heller RS, Leech CA, et al, Leptin suppression ofinsulin secretion by the activation of ATP-sensitive K+ channelsin pancreatic beta-cells[J]. Diabetes, 1997,46(6): 1087-1093.
5Emilsson V, Liu YL, Cawthorne MA, et al. Expression of thefunctional leptin receptor mRNA in pancreatic islets and directinhibitory action of leptin on insulin secretion[J]. Diabetes,1997, 46(2):313-316.
6Tartaglia LA, Dembski M, Weng X, et al. Identification andexpression cloning of a leptin receptor, OB-R[J], Cell, 1995,83(7): 1263-1271.
7Liao WL, Chen CC, Chang CT, et al Gene polymorphisms ofadiponectin and leptin receptor are associated with early onsetof type 2 diabetes mellitus in the Taiwan Residents population [J]. Int JObes, 2011, 36(6): 790-796.
8Qu Y, Yang Z, Jin F, et al. The haplotype identified in LEPRgene is associated with type 2 diabetes mellitus in NorthernChinese[J]. Diabetes Res Clin Pract, 2008, 81(1): 33-37.
9Gan R, Yang S. The 223A>G polymorphism of the leptinreceptor gene is associated with macroangiopathy in type 2diabetes mellitus [J]. Mol Biol Rep, 2012, 39(4): 4759-4764.
10Lu H, Sun J, Sun L, et al. Polymorphism of human leptin receptorgene is associated with type 2 diabetic patients complicated withnon-alcoholic fatty liver disease in China[J]. J GastroenterolHepatol, 2009, 24(2): 228-232.
